Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCLA.L Regulatory News (GCLA)

  • There is currently no data for GCLA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GCLA Responds to Shareholder Information Request

7 Apr 2022 16:54

RNS Number : 7047H
Grupo Clarin S.A.
07 April 2022
 

 

 

GRUPO CLARIN S.A.

Grupo Clarín Responds Shareholder Request for Additional Information

 

On 7 April 2022, Grupo Clarín S.A. (the "Company") informed the Argentine Securities Commission and the Buenos Aires Stock Exchange that it had exchanged additional notes with a shareholder in connection with the agenda of the Ordinary Annual Shareholders' Meeting to be held on 18 April 2022.

 

Attached as Exhibit A is a free translation of the Company's response.

 

Enquiries:

 

In Buenos Aires:

Samantha Olivieri

Grupo Clarín

Tel: +5411 4309 7104

Email: investors@grupoclarin.com 

 

In London:

Alex Money

Jasford IR

Tel: +44 20 3289 5300

Email: alexm@jasford.com 

 

In New York:

Camilla Ferreira / Marcella Ewerton

Fig Corporate Communications

Tel: +1 917 691 4047

Email: fig@fig.ooo

 

 

EXHIBIT A

 

FREE TRANSLATION

 

Buenos Aires, 7 April 2022

 

To the Shareholder of

Grupo Clarín S.A.

National Social Security Administration (ANSES)

Fondo de Garantía de Sustentabilidad

By Hand

Attn: Management Director for Corporate Affairs Mr. Director Benjamín Navarro - Coordinator Mrs. Paola Rolotti

 

Re: Shareholders' Meeting of 18.04.22. Request for additional information.

 

To whom it may concern,

 

I, Samantha Lee Olivieri, in my capacity as Person Responsible for Market Relations of Grupo Clarín S.A. (hereinafter, interchangeably, the "Company" or "Grupo Clarín") hereby address You in response to your request for information, issued by e-mail dated 5 April 2022.

 

Below, as requested, is a detail of the evolution of the Company's Legal Reserve since its creation and to date, specifying its current composition and its movements.

 

Legal Reserve

Amount

% of Equity + Equity Adjustment

Observations

Balance in Financial Statements as of 31/12/1999

-

0.0%

Balance in Financial Statements as of 31/12/2000

-

0.0%

The result of the irregular year 1999 was negative

Balance in Financial Statements as of 31/12/2001

-

0.0%

As of 12-2000 the Company had negative retained earnings

Balance in Financial Statements as of 31/12/2002

-

0.0%

As of 12-2001 the Company had negative retained earnings

Balance in Financial Statements as of 31/12/2003

-

0.0%

As of 12-2002 the Company had negative retained earnings

Balance in Financial Statements as of 31/12/2004

-

0.0%

As of 12-2003 the Company had negative retained earnings

Balance in Financial Statements as of 31/12/2005

-

0.0%

As of 12-2004 the Company had negative retained earnings

Balance in Financial Statements as of 31/12/2006

-

0.0%

As of 12-2005 the Company had negative retained earnings

Balance in Financial Statements as of 31/12/2007

-

0.0%

As of 12-2006 the Company had negative retained earnings

Creation of legal reserve resolved at the Annual Ordinary Shareholders' Meeting held on 24 April 2008

10,410,117

Balance in Financial Statements as of 31/12/2008

10,410,117

1.7%

Allocation to legal reserve resolved at the Annual Ordinary Shareholders' Meeting held on 23 April 2009

13,137,065

Balance in Financial Statements as of 31/12/2009

23,547,182

3.9%

Allocation to legal reserve resolved at the Annual Ordinary Shareholders' Meeting held on 22 April 2010

14,507,327

Balance in Financial Statements as of 31/12/2010

38,054,509

6.4%

Allocation to legal reserve resolved at the Annual Ordinary Shareholders' Meeting held on 28 April 2011

26,685,724

Balance in Financial Statements as of 31/12/2011

64,740,233

10.8%

Allocation to legal reserve resolved at the Annual Ordinary Shareholders' Meeting held on 26 April 2012

23,912,434

Balance in Financial Statements as of 31/12/2012

88,652,667

14.8%

Allocation to legal reserve resolved at the Annual Ordinary Shareholders' Meeting held on 25 April 2013

24,057,630

Balance in Financial Statements as of 31/12/2013

112,710,297

18.9%

Allocation to legal reserve resolved at the Annual Ordinary Shareholders' Meeting held on 29 April 2014

6,750,470

Balance in Financial Statements as of 31/12/2014

119,460,767

20.0%

Balance in Financial Statements as of 31/12/2015

119,460,767

20.0%

Balance in Financial Statements as of 31/12/2016

119,460,767

20.0%

Grupo Clarín Spinoff process (1 May 2017)

(75,081,092)

Balance in Financial Statements as of 31/12/2017

44,379,675

20.0%

Restatement of initial balance in terms of purchasing power as of 31/12/2018

37,392,184

Balance in Financial Statements as of 31/12/2018

81,771,859

3.3%

Reversal of Legal Reserve resolved at the Annual Ordinary Shareholders' Meeting held on 30 April 2019

(81,771,859)

Balance in Financial Statements as of 31/12/2019

-

0.0%

As of 12-2018 the Company had negative retained earnings

Balance in Financial Statements as of 31/12/2020

-

0.0%

As of 12-2019 the Company had negative retained earnings

Balance in Financial Statements as of 31/12/2021

-

0.0%

As of 12-2020 the Company had negative retained earnings

 

 

· In the event that [the shareholders] were to consider creating or allocating any amount to other reserves, we need a clear and detailed explanation of the reasons and convenience, expressing if such [creation or allocation] is reasonable and responds to a prudent administration, pursuant to Article 66, par. 3 and 70 of the General Companies Law

 

As shown in the "Proposal of the Board of Directors" included in the Annual Report corresponding to the accounting documents required under Art. 237 par. 1 of the General Companies Law that was duly published on the Financial Information Highway (AIF) the Board of Directors has proposed that all retained earnings as of 31 December 2021 be allocated to replenish the Legal Reserve pursuant to the CNV Rules (Art 5, Chapter III, Section II, Title IV).

Retained Earnings - Board Proposal

Amount

% of Equity + Equity Adjustment

Replenish legal reserve

1,039,043,355

13.46%

 

 

 

 

 

 

 

 

 

 

 

 

· We hereby request that you specify whether the Company has any restriction to the distribution of dividends that applies at the time of this Shareholders' Meeting. If a distribution of dividends will be considered, we ask that you inform in what term and under which methodology (in cash, in kind)

The Company is not under any restriction to distribute dividends other than the one imposed by the General Companies Law, which provides that dividends may not be distributed until the legal reserve has been replenished.

 

· Given that Resolution No. 777/18 of the CNV points out that the distribution of profits must be considered in the currency as of the date of that the Shareholders' Meeting is held by applying the price index corresponding to the month immediately preceding such meeting, we ask that you confirm if the proposal informed in this response will be restated. In such case, indicate the index applied to the calculation and the updated amounts.

 

The informed proposal will be restated pursuant to CNV Resolution No. 777/18 in the currency as of the date of the Shareholders' Meeting by applying the price index corresponding to the month immediately preceding the meeting, which has not yet been published at this time.

We hereby state for the record that this response will be uploaded onto the AIF for the knowledge of all shareholders of the Company.

 

We are at your disposal to make any clarifications that you may deem relevant.

 

Sincerely,

 

/s/ Samantha L. Olivieri

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STREDLFBLZLZBBX
Date   Source Headline
23rd Nov 20237:00 amRNSGrupo Clarín Delisting of Global Depositary Shares
23rd Nov 20237:00 amRNSExpected Delisting of Global Depositary Shares
13th Nov 20237:00 amRNS3rd Quarter and 9 Month Results
25th Oct 20233:24 pmRNSBuy out of minority shareholders in subsidiary
9th Oct 202312:57 pmRNSFormer employee files claim
9th Oct 202312:56 pmRNSCompany makes equity contribution
7th Sep 20235:35 pmRNSConsumer association files claim
14th Aug 20237:53 amRNSHalf-year Report
14th Jun 20234:06 pmRNSLeave of Absence
9th Jun 20238:57 amRNSLeave of Absence
15th May 20237:00 amRNS1st Quarter Results
2nd May 20237:04 amRNSAnnual Financial Report
2nd May 20237:00 amRNSAudit Committee
28th Apr 20236:25 pmRNSDirectorate Change
28th Apr 20236:19 pmRNSGCSA Holds Shareholders' Meeting
14th Apr 20237:00 amRNSResponse to Shareholder Information Request
12th Apr 20237:00 amRNSResponse to Shareholder Information Request
22nd Mar 20234:54 pmRNSReplacement: Annual Shareholders’ Meeting
21st Mar 20237:25 amRNSAnnual Shareholders’ Meeting
14th Mar 202311:20 amRNSCorrection: Leave of Absence
14th Mar 20237:00 amRNSLeave of Absence
13th Mar 20237:00 amRNSFull Year and Last Quarter 2022 Results
6th Mar 20237:00 amRNSWebcast to discuss 4Q and FY 2022 results
15th Feb 20239:19 amRNSMinority shareholder files claim
16th Jan 20236:15 pmRNSSecretary of Trade imposes Fine on Subsidiary
28th Dec 20227:00 amRNSDirectorate Change
28th Dec 20227:00 amRNSResult of Meeting
28th Dec 20227:00 amRNSResult of Meeting
7th Dec 20229:00 amRNSResult of Meeting
7th Dec 20229:00 amRNSLeave of Absence
2nd Dec 20221:42 pmRNSDirectorate Change
14th Nov 20227:25 amRNSNine months and Third Quarter 2022 Results
31st Oct 20228:07 amRNSNotice of Results
27th Oct 20227:00 amRNSNotice to Global Depository Receipt Holders
9th Sep 20226:20 pmRNSAGM Statement
6th Sep 20221:07 pmRNSAcquisition
26th Aug 20227:00 amRNSLeave of Absence
23rd Aug 20227:00 amRNSResponse to Shareholder Information Request
12th Aug 20227:00 amRNSFirst Half and Second Quarter 2022 Results
3rd Aug 20226:22 pmRNSGCLA Calls Extraordinary Shareholders’ Meeting
25th Jul 20226:18 pmRNSNotice of Results
14th Jul 20221:11 pmRNSGuarantee in favour of Tele Red Imagen S.A
6th Jul 20229:07 amRNSCourt of Appeals Nullifies Resolution
17th Jun 20227:00 amRNSResponse to Shareholder Information Request
16th Jun 20224:20 pmRNSAppellate Decision in Pol-Ka Dispute
12th May 20227:00 amRNS1st Quarter 2022 Results
3rd May 20227:00 amRNSWebcast presentation to discuss 1Q 2022 results
20th Apr 20228:46 amRNSMembership of Audit Committee
19th Apr 20227:00 amRNSDirectorate Change
19th Apr 20227:00 amRNSGrupo Clarin holds Shareholders' Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.